Epidemiology and Health

Korean Society of Epidemiology (한국역학회)
권호 표지

Metabolic Syndrome and Serum Alanine Aminotransferase Levels in Korean Adults: The Third Korea National Health and Nutrition Examination Survey(KNHANES III), 2005

대사증후군과 알라닌 아미노전이효소와의 관련성: 국민건강영양조사 제3기(2005년)

Han, Mi-Ah;Ryu, So-Yeon;Park, Jong;Kang, Myung Geun;Kim, Ki-Soon
한미아;류소연;박종;강명근;김기순

  • Published : 2008.06.01
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607 https://doi.org/10.2337/diabetes.37.12.1595
  2. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults: executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001; 285: 2486-97 https://doi.org/10.1001/jama.285.19.2486
  3. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndome. Diabetes 2001; 50: 1844-50 https://doi.org/10.2337/diabetes.50.8.1844
  4. Kim JM, Park JY, Nam HK, Kim JW, Park SK, Nam KJ et al. Prevalence of metabolic syndrome in type 2 DM patients with non-alcoholic fatty liver. J Korean Diabetes Assoc 2006; 30(6): 442-449 (Korean) https://doi.org/10.4093/jkda.2006.30.6.442
  5. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-1231 https://doi.org/10.1056/NEJMra011775
  6. Wanless IR, Lentz JS. Fatty liver hepatitis(steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990; 12(5): 1106-1110 https://doi.org/10.1002/hep.1840120505
  7. Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severly obese. Gastroenterology 2001; 121(1): 91-100 https://doi.org/10.1053/gast.2001.25540
  8. Yu AS, Keeffe EB. Nonalcoholic fatty liver disease. Rev Gastroenterol Disord 2002; 2: 11-9
  9. Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology 2002; 122: 1649-1657 https://doi.org/10.1053/gast.2002.33573
  10. Jimba S, Nakagami T, Takahashi M, Wakamatsu T, Hirota Y, Iwamoto Y, et al. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet Med 2005; 22: 1141-1145 https://doi.org/10.1111/j.1464-5491.2005.01582.x
  11. Park SH, Kim BI, Yoo TW, Kim JW, Cho YK, Sung IK, Park CY, et al. Nonalcoholic fatty liver disease and abnormal liver function test in the heSGPTh screen examinees: the relationship with insulin resistance. Korean J Gastroenterol 2003; 41: 366-373 (Korean)
  12. Oh SY, Cho YK, Kang MS, Yoo TW, Park JH, Kim HJ, et al. The association between increased alanine aminoransaminase activity and metabolic factors in nonalcoholic fatty liver disease. Metabolism 2006; 55: 1604-1609 https://doi.org/10.1016/j.metabol.2006.07.021
  13. Moon KW, Leem JM, Bae SS, Lee KM, Kim SH, Chae HB, et al. The prevalence of metabolic syndrome in patients with nonalcoholic fatty liver disease. Korean J Hepatol 2004; 10: 197-206 (Korean)
  14. Kim SM, Kim JA, Han JH, Cho KH, Yoon DK. Nonalcoholic fatty liver disease and metabolic syndrome in nonobese, nondiabetic adults. Korean J Obese 2006; 15(1): 44-51 (Korean)
  15. Daniel S, Ben-Menachem T, Vasudevan G, Ma CK, Blumenkehl M. Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients. Am J Gastroenterol 1999; 94: 3010-3014 https://doi.org/10.1111/j.1572-0241.1999.01451.x
  16. Pratt DS, Kaplan MM. Evaluation of abnormal liver enzyme results in asymptomatic patients. N Engl J Med 2000; 342: 1266-1271 https://doi.org/10.1056/NEJM200004273421707
  17. Tsai PY, Yen CJ, Li YC, Chiu TY, Chen CY, Jan CF. Association between abnormal liver function and risk factors for metabolic syndrome among freshmen. J Adolesc Health 2007; 41: 132-137 https://doi.org/10.1016/j.jadohealth.2007.03.002
  18. Meltzer AA, Everhart JE. Association between diabetes and elevated serum alanine aminoransaminase activity among Mexican Americans. Am J Epidemiol 1997; 146: 565-571 https://doi.org/10.1093/oxfordjournals.aje.a009315
  19. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55: 434-438
  20. 황재석. 비알코올성 지방간질환의 이해 및 관리. 소화기연관학회 춘계학술대회 2006; 0: 203-215
  21. 김재택. 당뇨병환자에서 간효소치 상승의 기전. 임상당뇨병 2006; 7(2): 120-123
  22. Yeon JE. Nonalcoholic fatty Liver disease: pathogenesis and treatment. Korean J Med 2006; 70(3):246-252 (Korean)
  23. 연종은. 간기능 검사의 원리와 이해. 소화기연관학회 춘계학술대회 2005; 0: 327-336
  24. Green RM, Flamm S. AGA technical review on the evaluation of liver chemistry tests. Gastroenterology 2002; 123: 1367-1384 https://doi.org/10.1053/gast.2002.36061
  25. Brunt EM. Nonalcoholic steatohepatitis. Semin Liver Dis 2004; 24: 3-20
  26. Ruhl CE, Everhart JE. Determinants of the association of overweight with elevated serum alanine aminoransaminase activity in the United States. Gastroenterology 2003; 124: 71-79 https://doi.org/10.1053/gast.2003.50004
  27. Nam SM, Yu HY, Lee MY, Koh JH, Shin JY, Shin YG, et al. Alcohol consumption, liver enzymes, and prevalence of metabolic syndrome in Korean aults men. J Korean Diabetes Assoc 2007; 31(3):253-260 (Korean) https://doi.org/10.4093/jkda.2007.31.3.253
  28. Cohen JA, Kaplan MM. The SGOT/SGPT ratio-an indicator of alcohol liver disease. Dig Dis Sci 1979; 24: 385-838 https://doi.org/10.1007/BF01297126
  29. Bacon BR, Farahvash MJ, Janney CG, Neuschwander- Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994; 107: 1103-1109 https://doi.org/10.1016/0016-5085(94)90235-6
  30. Diehl AM, Goodman Z, Ishak KG. Alcoholic liver disease in nonalcoholics: a clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 1988; 95: 1056-1062 https://doi.org/10.1016/0016-5085(88)90183-7
  31. Park HS, Han JH, Choi KM, Kim SM. Relation between elevated serum alanine aminoransaminase and metabolic syndrome in Korean adolescents. Am J Clin Nutr 2005; 82: 1046-1051 https://doi.org/10.1093/ajcn/82.5.1046
  32. Choi KM, Lee KW, Kim HY, Seo JA, Kim SG, Kim NH, et al. Association among serum ferritin, alanine aminotransferase levels, and metabolic syndrome in Korean postmenopausal women. Metabolism 2005; 54: 1510-1514 https://doi.org/10.1016/j.metabol.2005.05.018